Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by JLGeminion Apr 01, 2011 2:15pm

162 Views

Post# 18374359

RE: RE: Investment Strategy - Buy, Hold, Overweigh

Cravenraven predicted Oncolytics trading at $5.75 in January. He is so proud of the buy side manipulation. What is his strategy? He objects to my advice of hold, buy, overweight, use margin, and use your judgement. Is his advice to trust the market and sell on poor market performance?

How do you think the short position will play out? I am looking forward to the shorts being squeezed.

Bullboard Posts

Canadian psychedelic stock to supply MDMA to Yale